Insiders · Profile

Jung Cassie

Chief Operating Officer at Aquestive Therapeutics. Filing since 26 Nov 2024. CIK 0001960154

Company
Date
Role
Action
Shares
Amount
Of holding
10 Mar 2026
Chief Operating Officer
Sold at will
45,791
$191.09K
14.3%
15 Oct 2025
Chief Operating Officer
Sold on a plan
67,575
$473.70K
21.9%
4 Sep 2025
Chief Operating Officer
Sold on a plan
62,180
$310.90K
18.0%
26 Nov 2024
Chief Operating Officer
Sold at will
44
$214.06
100%
4 decisions on file.